Navigation Links
Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook
Date:2/28/2008

$(9,481) $(4,559) $(28,658) $(29,469)

Basic and diluted net loss

per common share $(0.22) $(0.13) $(0.69) $(0.88)

Shares used in computing

basic and diluted net loss

per common share 42,588 35,244 41,685 33,394

Condensed Balance Sheets

(in thousands)

December 31,

2007 2006

(unaudited)

Cash, cash equivalents,

restricted cash

and marketable securities $70,957 $64,087

Total assets $77,867 $71,187

Deferred revenue $3,268 $19,591

Total liabilities $18,307 $29,433

Total liabilities and

stockholders' equity $77,867 $71,187

Shares issued and outstanding 42,592 35,390


'/>"/>
SOURCE Kosan Biosciences Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Kosan Announces February 28, 2008 Conference Call and Webcast
2. Kosans Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer
3. Kosan Announces Third Quarter 2007 Financial Results
4. Kosan to Reacquire Epothilone Program From Roche
5. Kosan Biosciences to Host Research & Development Day on October 31, 2007
6. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
7. Kosan Biosciences to Present at the 2007 UBS Global Life Sciences Conference
8. Kosan Biosciences to Present at the Bear Stearns 20th Annual Healthcare Conference
9. Wyeth Announces Executive Change in Finance Organization
10. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
11. Pharmacopeia Announces Management Team Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)...  Neurotech Pharmaceuticals, Inc., announced today the first ... 2 clinical trial of NT-503 Encapsulated Cell Therapy ... choroidal neovascularization secondary to age related macular degeneration ... growth factor (VEGF) receptor protein continuously produced by ... proof-of-concept study will evaluate NT-503 ECT as a ...
(Date:9/2/2015)... NESS ZIONA, Israel , September ... BVXV, TASE: BVXV) today announced the intent of the National ... U.S. National Institutes of Health (NIH) within the Department of ... 2 trial to be held in the United ... examine the use of BiondVax,s universal flu vaccine candidate, Multimeric-001 ...
(Date:9/2/2015)... San Diego, CA (PRWEB) , ... September 02, ... ... from troubleshooting faults in manufacturing equipment, to creating professional commercial video content, to ... beautifully detailed views of fascinating events that go by too quickly to process ...
(Date:9/1/2015)... , Sept. 1, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... 17 th Annual Global Investment Conference sponsored by ... 8-10, 2015 at The St. Regis Hotel in ... James Sapirstein , Chief Executive Officer, will provide ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... OmniGuide, Inc., the developer of the first and ... bandgap technology, today announced the results of a pre-clinical ... methods in neurosurgery. In the study, surgeons from the ... produced in live brain tissue with fiber delivered CO2 ...
... July 6 Ikaria Holdings, Inc. and BioLineRx Ltd. ... an agreement to obtain a worldwide exclusive license to ... cardiac remodeling following acute myocardial infarction (AMI). , ... is administered via the coronary artery during standard catheterization ...
... 6 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. ... distributor of nationally branded therapeutic, natural skin and health ... signed an agreement with 3PL Worldwide, Inc., for all ... Farley CEO explains that "3PL Worldwide offers true multichannel ...
Cached Biology Technology:New Pre-Clinical Data on OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting in Brain Tissue 2New Pre-Clinical Data on OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting in Brain Tissue 3IKARIA(R) to In-License BioLineRx's BL-1040 2IKARIA(R) to In-License BioLineRx's BL-1040 3avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaa's Product 2
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/10/2015)... and TELTOW, Germany , ... Instruments (SMI), a world leader in Eye Tracking ... completion of its OEM Eye Tracking Platform for integration ... Tracking Platform contains reference designs for seamless integration of ... systems, virtual reality HMDs and augmented reality smart glasses. ...
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
Breaking Biology News(10 mins):HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... by Charles Darwin and confirmed that microbes can ... or trains - rather bacteria and fungi hitch-hike ... paper published in Environmental Microbiology, Dr. Anna Gorbushina ... of Geneva, Switzerland) and their colleagues analysed dust ...
... Launch Multi-agency Data Interoperability System, WALL, ... Bulletin Board: BKYI), a leader in finger-based ... its partner,DaProSystems today announced a contract award ... mobile data solution. Harrisonburg,s police,department has successfully ...
... Zucker Hillside Hospital campus of the Feinstein Institute for ... increase a persons risk for schizophrenia. In a study ... Academy of Sciences, the research team uncovered original evidence ... a recessive manner. A recessive trait is one that ...
Cached Biology News:Wireless Public Safety Solution From BIO-key(R) and DaProSystems Links Virginia Law Enforcement Agencies 2Wireless Public Safety Solution From BIO-key(R) and DaProSystems Links Virginia Law Enforcement Agencies 3Feinstein researchers develop new genetic method and identify novel genes for schizophrenia 2
Vitronectin Immunogen: Purified, full length, native human protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Guava has made microcapillary flow cytometry accessible ... experts alike will appreciate the latest addition ... Pluseasy to use, surprising affordable, and very ... system includes such features as absolute cell ...
...
Fingerprinting II Basic software is used for analyzing fingerprint sample types (electrophoretic gels, HPLC and other chromatographic patterns, spectrophotometric and densitometric curves)....
Biology Products: